Will the Phase 2 trial "Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer" reach primary completion on or before Jul 10, 2027?

Resolves Yes if ClinicalTrials.gov record NCT06791148 (The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School) shows an actual primary completion date on or before Jul 10, 2027. Registered date at generation: Jul 10, 2027.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Jul 10, 2027, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.